My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Athira Pharma, Inc. - Common Stock (NQ:ATHA)

6.750 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Athira Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >

4 Analysts Have This to Say About Athira Pharma ↗

June 23, 2022

Analysts have provided the following ratings for Athira Pharma (NASDAQ:ATHA) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022 ↗

June 23, 2022

Upgrades

Via Benzinga

Athira Pharma Shares Fall To 52-Week Low - Read Why ↗

June 22, 2022

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

10 Biggest Price Target Changes For Thursday: Alcoa, Travelers And More ↗

June 23, 2022

Morgan Stanley cut Westinghouse Air Brake Technologies Corporation (NYSE: WAB) price target from $113 to $94. Westinghouse Air Brake Technologies shares fell 1.7% to $82.36 in pre-market trading.

Via Benzinga

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More ↗

June 23, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

Dow Jumps 150 Points; Ocean Bio-Chem Shares Spike Higher ↗

June 22, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Wednesday.

Via Benzinga

Stocks Quietly Higher as Market Attempts to Extend Rally ↗

June 22, 2022

Stocks are modestly higher at midday.

Via Talk Markets

U.S. Stocks Turn Higher; Athira Pharma Shares Plummet ↗

June 22, 2022

U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 30 points on Wednesday.

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

June 22, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

Exela Technologies (XELA) Stock Soars After Securing $136 Million Contract ↗

June 22, 2022

Exela Technologies (XELA) stock is taking off on Wednesday after gaining a new $136 million customer contract that lasts for three years.

Via InvestorPlace

Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results ↗

June 22, 2022

Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.

Via InvestorPlace

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral ↗

June 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Athira Pharma Stock Is Plunging ↗

June 22, 2022

Athira Pharma Inc (NASDAQ: ATHA) shares are falling Wednesday after the company announced topline results from its exploratory ACT-AD Phase 2 study of fosgonimeton in patients with mild-to-moderate...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2022 ↗

April 21, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022 ↗

May 10, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO ↗

March 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 24, 2022 ↗

March 24, 2022

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...

Via Benzinga

Earnings Preview: Athira Pharma ↗

March 23, 2022

Athira Pharma (NASDAQ:ATHA) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

35 Stocks Moving In Friday's Mid-Day Session ↗

October 22, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) rose 1099% to $18.35. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition as traders circulated...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗

December 15, 2021

Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

Athira CEO Resigns After Data Manipulation Firestorm, But Alzheimer's Stock Pops ↗

October 22, 2021

Athira CEO Leen Kawas resigned after an investigation found she altered images.

Via Investor's Business Daily

Why Shares of Athira Pharma Are Climbing Today ↗

October 22, 2021

The clinical trial for its Alzheimer's drug is one step closer to completion.

Via The Motley Fool

The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs ↗

October 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas...

Via Benzinga

Rebuilding Connections, Fostering Growth: Synaptogenix Could Be A Beacon of Hope for Patients With Neurological Diseases ↗

October 05, 2021

Image by Gerd Altmann from Pixabay How well we think, feel and act rests in the hands of trillions of tiny connectors in our minds. Synapses play an integral role in how we...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs, And More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefited from the optimism that was set in motion by the solid start to the pharma reporting...

Via Talk Markets

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.